Clorox Expands Dietary Supplements Business, Buys Nutranext

An image of a person going over a financial report
Credit: Shutterstock photo

The Clorox CompanyCLX remains keen on making strategic partnerships with retail customers and evolving capabilities both in the physical world and online. With focus on investing in brands being a key part of its strategy, this consumer products' maker recently agreed to purchase Nutranext - the Florida-based dietary supplements leader - for $700 million.

The deal is expected to expand the Clorox's dietary supplements business, thereby accelerating growth of its top brands in the fast-growing categories alongside focusing on health and wellness. It also acquired the RenewLife brand, digestive health leader in May 2016, which has been significantly contributing to the Clorox's e-commerce and extended distribution in the retail businesses.

Expected to close in the fourth quarter of fiscal 2018, the deal is likely to reduce GAAP earnings by 7-11 cents per share in the quarter and 8-12 cents in fiscal 2019. Thereafter, the deal will be accretive to earnings in fiscal 2020. Clorox plans to finance the deal with cash and debt, while retaining its Debt/EBITDA ratio range of 2.0x to 2.5x.

Last year, Nutranext generated sales of nearly $200 million and the purchase price reflects about 3.5 times of sales. Around 90% of this multi-vitamins maker's revenue is generated in the United States. Its products are sold in the retail and e-commerce channels and through the direct-to-consumer business. Nutranext markets multi-vitamins under the Rainbow Light brand, specialty minerals under the Natural Vitality brand and supplements for hair, skin and nails under the Neocell brand, among others.

Though Clorox has a solid earnings surprise history, this Zacks Rank #3 (Hold) company witnessed significant pressure on gross margin in the second quarter of fiscal 2018. The margin contraction can be attributed to elevated input costs for commodities and tightening of transportation market, which are likely to continue in fiscal 2018. However, we believe deals like this are likely to expand Clorox's margins and the overall profitability.

In the past month, Clorox has inched up 0.1% faring better than the industry 's decline of 2%.

Three Hot Picks in the Consumer Staples Space

Post Holdings, Inc. POST has a long-term earnings growth rate of 14% and a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

United Natural Foods, Inc. UNFI , a Zacks Rank #1 stock, pulled off an average positive earnings surprise of 10.7% in the trailing four quarters.

Archer Daniels Midland Company ADM has a Zacks Rank #2 (Buy) and delivered a positive earnings surprise of 17.1% in the last quarter.

Breaking News: Cryptocurrencies Now Bigger than Visa

The total market cap of all cryptos recently surpassed $700 billion - more than a 3,800% increase in the previous 12 months. They're now bigger than Morgan Stanley, Goldman Sachs and even Visa! The new asset class may expand even more rapidly in 2018 as new investors continue pouring in and Wall Street becomes increasingly involved.

Zacks has just named 4 companies that enable investors to take advantage of the explosive growth of cryptocurrencies via the stock market.

Click here to access these stocks. >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

United Natural Foods, Inc. (UNFI): Free Stock Analysis Report

Post Holdings, Inc. (POST): Free Stock Analysis Report

Clorox Company (The) (CLX): Free Stock Analysis Report

Archer Daniels Midland Company (ADM): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More